Effect of an ethanol/trisodium citrate hemodialysis catheter locking solution on isolates of Candida albicans

Hemodialysis International

Volumn 12, Issue 3, 2008, Pages 342-347

  Maharaj, Anil R ^a   Zelenitsky, Sheryl A ^a,b   Vercaigne, Lavern M ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c Manitoba Renal Program   (Canada)

Author keywords

Candidemia; Catheter; Citrate; Ethanol; Hemodialysis; Infection

Indexed keywords

ALCOHOL; ANTICOAGULANT AGENT; CITRATE TRISODIUM; CITRIC ACID;

ARTICLE; BACTERIAL COUNT; CANDIDA ALBICANS; CANDIDIASIS; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; IN VITRO STUDY; INDWELLING CATHETER; INFECTION; MICROBIOLOGY; RENAL REPLACEMENT THERAPY;

ANTICOAGULANTS; CANDIDA ALBICANS; CANDIDIASIS; CATHETERS, INDWELLING; CITRATES; COLONY COUNT, MICROBIAL; ETHANOL; HUMANS; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS;

EID: 55949120416     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00279.x     Document Type: Article

References (33)

1. Canadian Institute for Health Information: Canadian Organ Replacement Register. 2006 Annual Report. Ottawa; 2006.
2. Jindal K, Chan CT, Deziel C, et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol. 2006; 17(Suppl 1):S1-S27.
3. National Kidney Foundation. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006; 48(Suppl 1):S248-S273.
4. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant. 2006; 21:721-728.
5. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int. 2002; 61:305-316.
6. Quarello F, Forneris G, Borca M, Pozzato M. Do central venous catheters have advantages over arteriovenous fistulas or grafts? J Nephrol. 2006; 19:265-279.
7. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999; 10:1045-1049.
8. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997; 127:275-280.
9. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis. 1999; 34: 1114-1124.
10. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs. 2001; 24:180-205.
11. U.S. Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
12. Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002; 61: 1136-1142.
13. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis. 1999; 29:239-244.
14. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance. Clin Infect Dis. 1999; 29:1164-1170.
15. Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S. Invasive Candida species infections: A 5 year population-based assessment. J Antimicrob Chemother. 2005; 56:532-537.
16. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003; 37:1172-1177.
17. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38: 161-189.
18. Takla TA, Zelenitsky SA, Vercaigne LM. Effect of ethanol/ trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections. J Vasc Access. 2007; 8:262-267.
19. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev. 2007; 20:133-163.
20. Puzniak L, Teutsch S, Powderly W, Polish L. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol. 2004; 25:628-633.
21. Raad I, Hanna H, Boktour M, et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004; 38:1119-1127.
22. Sung JM, Ko WC, Huang JJ. Candidaemia in patients with dialysis-dependent acute renal failure: Aetiology, predisposing and prognostic factors. Nephrol Dial Transplant. 2001; 16:2348-2356.
23. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol. 2003; 25: 616-621.
24. Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia of longterm intravascular devices in pediatric patients. Arch Pediatr Adolesc Med. 2006; 160:1049-1053.
25. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheterrelated bloodstream infections in home parenteral nutrition patients. J Parenter Enteral Nutr. 2007; 31:302- 305.
26. Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect. 2004; 49:20-22.
27. Maki DG, Crnich CJ, Safdar N. Successful use of a 25% alcohol lock solution for prevention of recurrent CVCrelated bloodstream infection in a patient on home TNA. Presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30, 2002; Washington, DC. Abstract.
28. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters-An effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant. 2007; 22:471-476.
29. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM. Trisodium citrate 4%-an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant. 2007; 22:477-483.
30. Bell AL, Gu X, Burczynski FJ, Vercaigne LM. Ethanol/trisodium citrate for hemodialysis catheter lock. Clin Nephrol. 2004; 62:369-373.
31. Bell AL, Jayaraman R, Vercaigne LM. Effect of ethanol/ trisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters. Clin Nephrol. 2006; 65:342-348.
32. Pfaller MA, Diekema DJ, Rinaldi MG, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: A 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol. 2005; 43:5848-5899.
33. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997; 24:1122-1128.